Analysis | Samples | Factors | Units |
---|---|---|---|
FT-ICR-MS Positive ion mode | Control1 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Positive ion mode | Control2 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Positive ion mode | Control3 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Positive ion mode | FAC1 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Positive ion mode | FAC2 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Positive ion mode | FAC3 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Positive ion mode | FAT1 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Positive ion mode | FAT2 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Positive ion mode | FAT3 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Positive ion mode | CKC1 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Positive ion mode | CKC2 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Positive ion mode | CKC3 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Positive ion mode | CKT1 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Positive ion mode | CKT2 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Positive ion mode | CKT3 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Positive ion mode | KC1 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Positive ion mode | KC2 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Positive ion mode | KC3 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Positive ion mode | OA1 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Positive ion mode | OA2 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Positive ion mode | OA3 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Positive ion mode | PA1 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |
FT-ICR-MS Positive ion mode | PA2 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |
FT-ICR-MS Positive ion mode | PA3 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |
FT-ICR-MS Negative ion mode | Control1 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Negative ion mode | Control2 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Negative ion mode | Control3 | Concentration (uM):0 | Treatment_compound:BSA | Peak area |
FT-ICR-MS Negative ion mode | FAC1 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Negative ion mode | FAC2 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Negative ion mode | FAC3 | Concentration (uM):500 | Treatment_compound:CB-cis | Peak area |
FT-ICR-MS Negative ion mode | FAT1 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Negative ion mode | FAT2 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Negative ion mode | FAT3 | Concentration (uM):500 | Treatment_compound:CB-trans | Peak area |
FT-ICR-MS Negative ion mode | CKC1 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Negative ion mode | CKC2 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Negative ion mode | CKC3 | Concentration (uM):500 | Treatment_compound:CK-cis | Peak area |
FT-ICR-MS Negative ion mode | CKT1 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Negative ion mode | CKT2 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Negative ion mode | CKT3 | Concentration (uM):500 | Treatment_compound:CK-trans | Peak area |
FT-ICR-MS Negative ion mode | KC1 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Negative ion mode | KC2 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Negative ion mode | KC3 | Concentration (uM):500 | Treatment_compound:K-cis | Peak area |
FT-ICR-MS Negative ion mode | OA1 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Negative ion mode | OA2 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Negative ion mode | OA3 | Concentration (uM):500 | Treatment_compound:Oleic acid | Peak area |
FT-ICR-MS Negative ion mode | PA1 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |
FT-ICR-MS Negative ion mode | PA2 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |
FT-ICR-MS Negative ion mode | PA3 | Concentration (uM):500 | Treatment_compound:Palmitic acid | Peak area |